Rita A. Karachun - 04 Jun 2024 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Director
Signature
/s/ Bryan McMichael, as Attorney-in-Fact for Rita A. Karachun
Issuer symbol
CHRS
Transactions as of
04 Jun 2024
Net transactions value
$0
Form type
4
Filing time
05 Jun 2024, 18:57:54 UTC
Previous filing
05 Jun 2024
Next filing
13 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Award $0 +168,000 $0.000000 168,000 04 Jun 2024 Common Stock 168,000 $1.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 1/3rd of the total number of shares on the one year anniversary of June 4, 2024 and 1/36th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.